Specialists of the domestic pharmaceutical company Farmak have developed and brought to market a drug for the treatment of severe conditions, chronic cerebrovascular disorders and mental activity disorders – Gliaton (choline alfoscerate). The new drug is produced in the form of a solution for injection in 1000 mg ampoules No. 5.
Farmak is actively working in the sphere of treatment of cardiovascular diseases. In particular, much attention is given to ensure comprehensive effective and affordable treatment of severe and chronic cerebrovascular disorders and mental activity disorders. To achieve this objective, the company's specialists have developed and brought to market the drug product Gliaton (choline alfoscerate).
Gliaton is indicated in the acute phase of craniocerebral trauma, in impaired consciousness, coma, focal hemispheric symptoms; degenerative involutional psychoorganic syndromes, cerebrovascular insufficiency; primary and secondary mental disorders, memory impairment, confusion and disorientation. The drug is also indicated in emotional instability, irritability, indifference; pseudo melancholy in the elderly.
Gliaton is the drug that “awakens” (brings) patients out of comas, improves patients’ quality of life: improves memory, mental activity after injuries or as a result of cerebrovascular insufficiency.
The course of treatment with the drug is 2-3 weeks.
Each city or town has its own traditions. We follow the old and develop the new ones ourselves. It has become a good tradition for Farmak to congratulate Shostka on its Town Day in a sporty way. The anniversary race “Farmak: Run for Your Health” has been held by the Company for the fifth time. […]
The 5th anniversary race organized by Farmak on the occasion of Shostka Town Day will be held with the support of the local authorities in an offline format under the motto “Run a race and take care of your health!” The race will take place on September 3 in Shostka as part of the celebration of […]
TOP 50 successful Ukrainian brands with a stable reputation and a high level of customer confidence have been determined by the Focus expert magazine. Farmak as the Ukrainian pharmaceutical market leader is among the best. The rating includes both brand companies and brand products from different segments: retail, pharmaceuticals, food industry, telecommunic...